Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
These Stocks Are Moving the Most Today: Roivant Sciences, Textainer, Okta, Microsoft, Alphabet
2023-10-23 16:50
Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion, Textainer is being acquired for about $2.1 billion, and Microsoft and Alphabet lead a busy earnings week.
You Might Like...
EA FC 24 Web App Release Date
Fortnite Downtime Today (Nov. 23): When Servers Be Back Up
Are There NBA 2K24 Mods?
The 5 best AI chatbots of 2023 (so far)
How to watch French Netflix for free
Husband hits back after being called too ugly for his wife
Hacker Deepfakes Employee's Voice in Phone Call to Breach IT Company
Elusive Ernie: China's new chatbot has a censorship problem